This pragmatic randomized controlled trial aimed to assess the effect of a passive display of artificial intelligence (AI)-based predictive analytics on hours free of clinical deterioration events ...
In this phase 2b, double-blind, placebo-controlled trial, eligible patients with gMG who tested negative for autoantibodies to MuSK were randomized 1:1 to receive six once-weekly intravenous infusions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results